Defective DNA endonuclease activity on anthramycin treated DNA in xeroderma pigmentosum and mouse melanoma cells

Dwight E. Lee, Anthony Okorodudu, W. Clark Lambert, Muriel W. Lambert

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Nine separate DNA endonuclease activities from non-histone chromatin proteins and a corresponding set from the nucleoplasm of normal human and xeroderma pigmentosum, complementation group A, lymphoblastoid and Cloudman mouse melanoma cells, obtained by isoelectric focusing, were tested against circular duplex phage PM2 DNA previously treated with anthramycin. A marked increase in activity against anthramycin treated DNA was found in normal human lymphoblastoid cells in a chromatin fraction with pI 4.6, with lesser increases at pI's 3.9 and 5.4 and a nucleoplasmic fraction at pI 4.6. In the nuclear proteins of xeroderma pigmentosum and mouse melanoma cells, however, no increase in activity against anthramycin DNA could be detected in any fraction.

Original languageEnglish (US)
Pages (from-to)395-402
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume107
Issue number1
DOIs
StatePublished - Jul 16 1982
Externally publishedYes

Fingerprint

Anthramycin
Xeroderma Pigmentosum
Deoxyribonuclease I
Chromatin
Melanoma
Bacteriophages
DNA
Nuclear Proteins
Isoelectric Focusing
Proteins
anthramycin-DNA

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Defective DNA endonuclease activity on anthramycin treated DNA in xeroderma pigmentosum and mouse melanoma cells. / Lee, Dwight E.; Okorodudu, Anthony; Lambert, W. Clark; Lambert, Muriel W.

In: Biochemical and Biophysical Research Communications, Vol. 107, No. 1, 16.07.1982, p. 395-402.

Research output: Contribution to journalArticle

@article{e437c77d15564ac4b8f55c61633515cd,
title = "Defective DNA endonuclease activity on anthramycin treated DNA in xeroderma pigmentosum and mouse melanoma cells",
abstract = "Nine separate DNA endonuclease activities from non-histone chromatin proteins and a corresponding set from the nucleoplasm of normal human and xeroderma pigmentosum, complementation group A, lymphoblastoid and Cloudman mouse melanoma cells, obtained by isoelectric focusing, were tested against circular duplex phage PM2 DNA previously treated with anthramycin. A marked increase in activity against anthramycin treated DNA was found in normal human lymphoblastoid cells in a chromatin fraction with pI 4.6, with lesser increases at pI's 3.9 and 5.4 and a nucleoplasmic fraction at pI 4.6. In the nuclear proteins of xeroderma pigmentosum and mouse melanoma cells, however, no increase in activity against anthramycin DNA could be detected in any fraction.",
author = "Lee, {Dwight E.} and Anthony Okorodudu and Lambert, {W. Clark} and Lambert, {Muriel W.}",
year = "1982",
month = "7",
day = "16",
doi = "10.1016/0006-291X(82)91717-X",
language = "English (US)",
volume = "107",
pages = "395--402",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Defective DNA endonuclease activity on anthramycin treated DNA in xeroderma pigmentosum and mouse melanoma cells

AU - Lee, Dwight E.

AU - Okorodudu, Anthony

AU - Lambert, W. Clark

AU - Lambert, Muriel W.

PY - 1982/7/16

Y1 - 1982/7/16

N2 - Nine separate DNA endonuclease activities from non-histone chromatin proteins and a corresponding set from the nucleoplasm of normal human and xeroderma pigmentosum, complementation group A, lymphoblastoid and Cloudman mouse melanoma cells, obtained by isoelectric focusing, were tested against circular duplex phage PM2 DNA previously treated with anthramycin. A marked increase in activity against anthramycin treated DNA was found in normal human lymphoblastoid cells in a chromatin fraction with pI 4.6, with lesser increases at pI's 3.9 and 5.4 and a nucleoplasmic fraction at pI 4.6. In the nuclear proteins of xeroderma pigmentosum and mouse melanoma cells, however, no increase in activity against anthramycin DNA could be detected in any fraction.

AB - Nine separate DNA endonuclease activities from non-histone chromatin proteins and a corresponding set from the nucleoplasm of normal human and xeroderma pigmentosum, complementation group A, lymphoblastoid and Cloudman mouse melanoma cells, obtained by isoelectric focusing, were tested against circular duplex phage PM2 DNA previously treated with anthramycin. A marked increase in activity against anthramycin treated DNA was found in normal human lymphoblastoid cells in a chromatin fraction with pI 4.6, with lesser increases at pI's 3.9 and 5.4 and a nucleoplasmic fraction at pI 4.6. In the nuclear proteins of xeroderma pigmentosum and mouse melanoma cells, however, no increase in activity against anthramycin DNA could be detected in any fraction.

UR - http://www.scopus.com/inward/record.url?scp=0020456516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020456516&partnerID=8YFLogxK

U2 - 10.1016/0006-291X(82)91717-X

DO - 10.1016/0006-291X(82)91717-X

M3 - Article

C2 - 6215036

AN - SCOPUS:0020456516

VL - 107

SP - 395

EP - 402

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -